3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma DS

Dividend Select 15 Corp. Equity Shares

Stock factsheet

TickerDS
ExchangeTSX
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 35 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

The Companys investment objectives are to provide holders of the Shares of the Company (Shareholders) with (i) monthly cash distributions, plus (ii) the opportunity for capital appreciation, through investment in the common shares of the Portfolio Companies. The Company has been created to provide investors with an opportunity to invest in a portfolio (the Portfolio) of 15 Canadian companies (the Portfolio Companies) whose shares offer investors an above-average dividend yield, and which have shown solid earnings growth and have a history of capital appreciation. The Portfolio Companies will be selected from among 20 companies (the Portfolio Universe) listed on the Toronto Stock Exchange (TSX) set out below: Bank of Montreal Royal Bank of Canada BCE Inc. Shoppers Drug Mart Corporation Canadian Imperial Bank of Sun Life Financial Inc. Commerce TELUS Corporation CI Financial Corp. The Bank of Nova Scotia Enbridge Inc.

Company description as published by the issuer via TMX Money.

Share price

Price data from TradingView, possibly delayed. Not investment advice.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Dividend Select 15 Corp. Equity SharesDS TSX35 Mio. USD
LSL Pharma Group Inc. LSLTSXV 34 Mio. USD
Vext Science, Inc. VEXTCSE 34 Mio. USD
BetterLife Pharma Inc. BETRCSE 33 Mio. USD
NexgenRx Inc. NXGTSXV 33 Mio. USD
MedMira Inc. MIRTSXV 32 Mio. USD
Perimeter Medical Imaging AI Inc. PINKTSXV 32 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.